SEARCH HEALTH CONDITIONS BY ALPHABETS
Metagonimus Yokogawai, Intestinal Fluke
Medications for Metagonimus yokogawai, Intestinal Fluke
Around Metagonimus yokogawai, Intestinal Fluke: Metagonimus yokogawai, an intestinal fluke widely spread at the Far East and the Balkans and one of the tiniest (1--2.5 millimeter ) flukes trapping humans, is passed out of Semisulcospira snails to cyprinoid fish and then to humans as well as different fish-eating mammals and birds.
Drugs Used to Treat Metagonimus yokogawai, Intestinal Fluke
The following set of medications have been utilized at the treatment of this illness, or in some way associated with.
| Drug title | Rx / OTC | Pregnancy | CSA | Alcohol | Reviews | Rating | Popularity |
|---|---|---|---|---|---|---|---|
| Biltricide | Rx | B | N | Insert inspection | 0.0 | ||
Generic title: praziquantel systemic Drug course: anthelmintics For users: dose, interactions, side effects For specialists: AHFS DI Monograph, Prescribing Information | |||||||
| praziquantel | Rx | B | N | Insert inspection | 0.0 | ||
Generic title: praziquantel systemic Brand title: Biltricide Drug course: anthelmintics For users: dose, interactions, For specialists: Az Drug Facts, AHFS DI Monograph, Prescribing Information | |||||||
Legend
| Rx | Prescription-only |
|---|---|
| OTC | Over the Counter |
| Rx/OTC | Prescription or Over the Counter |
| Off Label | This medication Might Not Be approved by the FDA for the treatment of this ailment. |
| Pregnancy Category | |
|---|---|
| A | sufficient and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (also there is no evidence of risk in later trimesters). |
| B | Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no sufficient and well-controlled studies in pregnant women. |
| C | Animal reproduction studies have demonstrated an adverse effect in the fetus and there are no sufficient and well-controlled studies in humans, but potential benefits may warrant used in pregnant women despite potential risks. |
| D | there was positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant used in pregnant women despite potential risks. |
| X | Studies in animals or humans have demonstrated fetal abnormalities or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and also the risks involved in used in pregnant women obviously outweigh potential rewards. |
| N | FDA has not classified this drug. |
| Controlled Substances Act (CSA) Schedule | |
|---|---|
| N | isn`t subject to the Controlled Substances Act. |
| 1 | features a higher possibility of abuse. Has no currently accepted medical use in treatment in the United States. There`s a lack of accepted safety for use under medical supervision. |
| 2 | features a higher possibility of abuse. Includes a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Psychotherapy can lead to acute physical or psychological dependency. |
| 3 | features a possibility for abuse less than individuals in schedules 1 and 2 2. Includes a currently accepted medical use in treatment in the United States. Psychotherapy can lead to moderate or low physical dependence or high psychological dependence. |
| 4 | features a minimal potential for abuse relative to individuals in program 3. It has a currently accepted medical use in treatment in the United States. Psychotherapy can lead to limited physical dependence or psychological dependence relative to individuals in program 3. |
| 5 | features a minimal potential for abuse relative to individuals in program 4. Includes a currently accepted medical use in treatment in the United States. Psychotherapy can lead to limited physical dependence or psychological dependence relative to individuals in program 4. |
| Infection | |
|---|---|
| X | Interacts with Medication. |
Browse Treatment Plans
- A
- B
- C
- D
- E
- F
- G
- H
- that I
- J
- K
- L
- M
- N
- O
- P
- Q
- Janin
- S
- T
- U
- V
- W
- X
- Y
- Z
Further advice
Always consult your physician to ensure the information relates to your personal circumstances.
- Measles Prophylaxis
- Mechanical Ventilation
- Mediastinal Infection
- Medical Procedures
- Medication Allergy
- Megaloblastic Anemia
- Meibomian Cyst
- Meibomian Gland Lipogranuloma
- Melanoma, Metastatic
- Melioidosis
- Meningeal Leukemia
- Meningitis, Haemophilus Influenzae
- Meningitis, Listeriosis
- Meningitis, Lymphomatous
- Meningitis, Meningococcal
- Meningitis, Pneumococcal
- Meningitis, Streptococcus Group B
- Meningococcal Meningitis Prophylaxis
- Mental Health
- Mental Retardation
- Mercury Poisoning
- MERS‐CoV
- Mesenteric Ischemia
- Mesothelioma, Malignant
- Mesothelioma, Malignant Pleural
- Metagonimus Yokogawai, Intestinal Fluke
- Meteorism
- Methanol Poisoning
- Methemoglobinemia
- Methotrexate Overdosage
- Methotrexate Rescue
- Mevalonate Kinase Deficiency
Top USA Pharma Companies
Product Categories
Popular Categories
Health Condition
- Measles Prophylaxis
- Mechanical Ventilation
- Mediastinal Infection
- Medical Procedures
- Medication Allergy
- Megaloblastic Anemia
- Meibomian Cyst
- Meibomian Gland Lipogranuloma
- Melanoma, Metastatic
- Melioidosis
- Meningeal Leukemia
- Meningitis, Haemophilus Influenzae
- Meningitis, Listeriosis
- Meningitis, Lymphomatous
- Meningitis, Meningococcal
- Meningitis, Pneumococcal
- Meningitis, Streptococcus Group B
- Meningococcal Meningitis Prophylaxis
- Mental Health
- Mental Retardation
- Mercury Poisoning
- MERS‐CoV
- Mesenteric Ischemia
- Mesothelioma, Malignant
- Mesothelioma, Malignant Pleural
- Metagonimus Yokogawai, Intestinal Fluke
- Meteorism
- Methanol Poisoning
- Methemoglobinemia
- Methotrexate Overdosage
- Methotrexate Rescue
- Mevalonate Kinase Deficiency
Easily find an affordable health insurance plan
